Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death
Sylvain Garciaz(Centre National de la Recherche Scientifique), Mark A. Dawson(The University of Melbourne), Brian Liddicoat(Broad Institute), Lorey Smith(Peter MacCallum Cancer Centre), Andrew H. Wei(The Royal Melbourne Hospital), Marian L. Burr(Australian National University), Ali Motazedian(Peter MacCallum Cancer Centre), Yih-Chih Chan(The University of Melbourne), Georg Ramm(Garvan Institute of Medical Research), Estelle Duprez(Centre National de la Recherche Scientifique), Tatiana Cañeque(Centre National de la Recherche Scientifique), Kristin Brown(The University of Melbourne), Mathilde Poplineau(Centre National de la Recherche Scientifique), Andrew A. Guirguis(Peter MacCallum Cancer Centre), Kah Lok Chan, Caitlin L. Rowe(Discovery Institute), Kevin Tran(The University of Melbourne), James A. Kuzich(The University of Melbourne), David C.S. Huang(Indonesia International Institute for Life Sciences), Enid Y.N. Lam(The University of Melbourne), Sebastian Müller(Freie Universität Berlin), Fiona C. Brown(Walter and Eliza Hall Institute of Medical Research), Véronique Litalien(Monash University), Andrew G. Cox(The University of Melbourne), Kate McArthur(Discovery Institute), Giovanna Pomilio(Institut Pprime), Laura MacPherson(Natural Resources Canada), Sarah‐Jane Dawson(The University of Melbourne), Raphaël Rodriguez(Centre National de la Recherche Scientifique)
HAL (Le Centre pour la Communication Scientifique Directe)
March 1, 2023
Cited by 34
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k